home / stock / ubx / ubx news


UBX News and Press, Unity Biotechnology Inc. From 08/18/22

Stock Information

Company Name: Unity Biotechnology Inc.
Stock Symbol: UBX
Market: NASDAQ
Website: unitybiotechnology.com

Menu

UBX UBX Quote UBX Short UBX News UBX Articles UBX Message Board
Get UBX Alerts

News, Short Squeeze, Breakout and More Instantly...

UBX - UNITY Biotechnology trades lower on pricing upsized $45.0M securities offering

UNITY Biotechnology ( NASDAQ: UBX ) is down 4.95% after-hours after the firm has priced an upsized underwritten public offering of 64,285,714 shares of its common stock and accompanying warrants to purchase up to 64,285,714 shares of common stock at a combined public offer...

UBX - UNITY Biotechnology Announces Pricing of Upsized Underwritten Public Offering

SOUTH SAN FRANCISCO, Calif., Aug. 17, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (Nasdaq:UBX), a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced the pricing of an upsized underwritten public offering ...

UBX - Sanofi, Sibanye Stillwater, Option Care Health among premarket losers' pack

Blueprint Medicines ( BPMC ) -13% on reports to seek label expansion for systemic mastocytosis therapy after trial win . Artelo Biosciences ( ARTL ) -13% . Krispy Kreme ( DNUT ) -12% on Q2 earnings release . Forza X1 ( FRZA ) -12% . ...

UBX - Unity Biotech sheds 9% on $25M common stock offering

The shares of Unity Biotechnology ( NASDAQ: UBX ) lost ~9% in the post-market Tuesday after the clinical-stage biotech announced it started an underwritten public offering of $25M worth of its common stock. A decision to grant a 30-day option for underwriters is also u...

UBX - UNITY Biotechnology Announces Proposed Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., Aug. 16, 2022 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) (Nasdaq:UBX), a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today announced that it has commenced a proposed underwritten public of...

UBX - Unity Biotechnology, Inc. 2022 Q2 - Results - Earnings Call Presentation

The following slide deck was published by Unity Biotechnology, Inc. in conjunction with their 2022 Q2 earnings call. For further details see: Unity Biotechnology, Inc. 2022 Q2 - Results - Earnings Call Presentation

UBX - Viridian, TherapeuticsMD top healthcare gainers; IDEAYA, Apexigen lead losers' pack

Gainers: Viridian Therapeutics VRDN +45% . TherapeuticsMD TXMD +21% . Unity Biotechnology UBX +21% . Brainstorm Cell Therapeutics BCLI +12% . Genprex GNPX +10% . Losers: IDEAYA Biosciences IDYA -33% . Apexigen ( APGN ) -15%...

UBX - Unity extends gains on data for lead asset in diabetic macular edema

After a 54% rise on Friday, the shares of clinical-stage biotech Unity Biotechnology ( NASDAQ: UBX ) continue to trade higher on rising volumes in the pre-market as Wall Street reacts to the company’s Phase 2 data for lead candidate UBX1325 in diabetic macular edema. ...

UBX - Hot Penny Stocks to Add to Your Watchlist Right Now

3 Penny Stocks to Add to Your Watchlist If you’re looking for the best penny stocks to buy, now is a great time to make a watchlist. In the past year or so, we’ve seen an increased amount of volatility across the board. This means that the potential for large swings in bot...

UBX - DWAC Stock Stumbles Ahead of Merger Extension Vote

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Ink Drop / Shutterstock Digital World Acquisition (NASDAQ: DWAC ) stock is sliding on Friday as the company waits for a vote from shareholders to extend its merger window with Truth Social . Truth S...

Previous 10 Next 10